145 related articles for article (PubMed ID: 25684636)
1. Recent trends in testosterone testing, low testosterone levels, and testosterone treatment among Veterans.
Walsh TJ; Shores MM; Fox AE; Moore KP; Forsberg CW; Kinsey CE; Heckbert SR; Zeliadt S; Thompson ML; Smith NL; Matsumoto AM
Andrology; 2015 Mar; 3(2):287-92. PubMed ID: 25684636
[TBL] [Abstract][Full Text] [Related]
2. Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over age 70 with low testosterone levels.
Kenny AM; Prestwood KM; Raisz LG
Endocr Res; 2000 May; 26(2):153-68. PubMed ID: 10921445
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
Grober ED; Khera M; Soni SD; Espinoza MG; Lipshultz LI
Int J Impot Res; 2008; 20(2):213-7. PubMed ID: 17898800
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
5. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.
Layton JB; Li D; Meier CR; Sharpless JL; Stürmer T; Jick SS; Brookhart MA
J Clin Endocrinol Metab; 2014 Mar; 99(3):835-42. PubMed ID: 24423353
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
[TBL] [Abstract][Full Text] [Related]
7. Who Gets Testosterone? Patient Characteristics Associated with Testosterone Prescribing in the Veteran Affairs System: a Cross-Sectional Study.
Jasuja GK; Bhasin S; Reisman JI; Hanlon JT; Miller DR; Morreale AP; Pogach LM; Cunningham FE; Park A; Berlowitz DR; Rose AJ
J Gen Intern Med; 2017 Mar; 32(3):304-311. PubMed ID: 27995426
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets.
Pastuszak AW; Mittakanti H; Liu JS; Gomez L; Lipshultz LI; Khera M
J Androl; 2012; 33(5):927-37. PubMed ID: 22403285
[TBL] [Abstract][Full Text] [Related]
9. Association Between Testosterone Replacement Therapy and the Incidence of DVT and Pulmonary Embolism: A Retrospective Cohort Study of the Veterans Administration Database.
Sharma R; Oni OA; Chen G; Sharma M; Dawn B; Sharma R; Parashara D; Savin VJ; Barua RS; Gupta K
Chest; 2016 Sep; 150(3):563-71. PubMed ID: 27179907
[TBL] [Abstract][Full Text] [Related]
10. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract][Full Text] [Related]
11. Low serum testosterone and mortality in male veterans.
Shores MM; Matsumoto AM; Sloan KL; Kivlahan DR
Arch Intern Med; 2006 Aug 14-28; 166(15):1660-5. PubMed ID: 16908801
[TBL] [Abstract][Full Text] [Related]
12. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
13. Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013.
Layton JB; Kim Y; Alexander GC; Emery SL
JAMA; 2017 Mar; 317(11):1159-1166. PubMed ID: 28324090
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of testosterone deficiency after spinal cord injury.
Durga A; Sepahpanah F; Regozzi M; Hastings J; Crane DA
PM R; 2011 Oct; 3(10):929-32. PubMed ID: 22024324
[TBL] [Abstract][Full Text] [Related]
15. The appropriateness and persistence of testosterone replacement therapy in Ontario.
Martins D; Yao Z; Tadrous M; Shah BR; Juurlink DN; Mamdani MM; Gomes T;
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):119-126. PubMed ID: 27528454
[TBL] [Abstract][Full Text] [Related]
16. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
[TBL] [Abstract][Full Text] [Related]
17. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
[TBL] [Abstract][Full Text] [Related]
18. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Men Undergoing Testosterone Replacement Therapy and Adherence to Follow-up Recommendations in Metropolitan Multicenter Health Care System.
Malik RD; Wang CE; Lapin B; Lakeman JC; Helfand BT
Urology; 2015 Jun; 85(6):1382-8. PubMed ID: 25862121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
